Are IBD drugs safe in pregnancy? large french study investigates

NCT ID NCT03134508

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study analyzed data from over 8,700 pregnant women with inflammatory bowel disease (Crohn's or ulcerative colitis) to see how well doctors follow guidelines when prescribing antiTNFα drugs and whether the benefits outweigh the risks for both mother and baby. Researchers looked at complications related to the disease, treatment, and pregnancy, as well as infections in babies during their first year. The goal is to provide clearer evidence for safer treatment decisions during pregnancy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
antiTNFα (anti-tumor necrosis factor alpha) drugs
What this could lead to
If successful, this could help doctors make safer decisions about using antiTNFα drugs during pregnancy in women with inflammatory bowel disease.
What could go wrong
This is an observational study using existing hospital records, not a controlled trial. It can show associations but cannot prove cause and effect. Results may not apply to other countries or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chu de Dijon

    Dijon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.